Skip to Main Content

INFORMATION FOR

    Monique Evangeline Hinchcliff, MD, MS

    Associate Professor of Medicine (Rheumatology, Allergy & Immunology)
    DownloadHi-Res Photo

    Are You a Patient?

    View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.

    View Doctor Profile

    Additional Titles

    Director of Yale Scleroderma Program, Rheumatology, Allergy, & Immunology

    Director of Clinical and Translational Research, Internal Medicine: Rheumatology

    Associate Director of the Clinical and Translational Research Accelerator at Yale, Internal Medicine

    About

    Titles

    Associate Professor of Medicine (Rheumatology, Allergy & Immunology)

    Director of Yale Scleroderma Program, Rheumatology, Allergy, & Immunology; Director of Clinical and Translational Research, Internal Medicine: Rheumatology; Associate Director of the Clinical and Translational Research Accelerator at Yale, Internal Medicine

    Biography

    Dr. Monique Hinchcliff is Director of Clinical and Translational Research for Rheumatology, Allergy & Immunology at the Yale School of Medicine and the Director of the Yale Scleroderma Program. She received her medical degree from the Rosalind Franklin University Chicago Medical School and completed her medicine residency at Norwalk Hospital in Connecticut.  She completed rheumatology fellowship training at Northwestern University Feinberg School of Medicine in Chicago, IL while earning a Master of Science degree in Clinical Investigation. 

    Her research program includes clinical, interventional and observational studies, with the goal of better understanding systemic sclerosis and identifying new and repurposed treatments for patients with systemic sclerosis. She has may active research collaborations both in the US and abroad. Clinically, Dr. Hinchcliff leads a team of multidisciplinary specialists with expertise in caring for patients with systemic sclerosis. She participates in ongoing clinical trials in order to give patients access to the latest treatments that may be beneficial.

    Appointments

    Education & Training

    MS
    Northwestern University (2010)
    MD
    Rosalind Franklin University of Medicine and Science, The Chicago Medical School (2001)
    BA
    Boston College, Music, Piano Performance (1995)

    Research

    Overview

    Medical Research Interests

    Artificial Intelligence; Microvascular Rarefaction; Pulmonary Fibrosis; Raynaud Disease; Scleroderma, Diffuse; Scleroderma, Limited; Scleroderma, Localized; Scleroderma, Systemic

    Research at a Glance

    Yale Co-Authors

    Frequent collaborators of Monique Evangeline Hinchcliff's published research.

    Publications

    2024

    2023

    Clinical Trials

    Current Trials

    Academic Achievements & Community Involvement

    • activity

      Board of Medicine Directors

    • activity

      Composite responder Index for Scleroderma Trials Assessing Limited scleroderma

    • activity

      Arthritis Research and Therapy

    • activity

      Journal of Scleroderma

    • activity

      Yale Pulmonary Hypertension Steering Committee

    Clinical Care

    Overview

    Monique Hinchliff, MD, is a rheumatologist specializing in scleroderma, a rheumatologic disease that causes chronic hardening of skin and connective tissues. She is also the director of the Yale Medicine Scleroderma Program.

    Dr. Hinchcliff received her medical degree from the Rosalind Franklin University Chicago Medical School and completed her residency at Norwalk Hospital in Connecticut. She completed a rheumatology fellowship training at Northwestern University Feinberg School of Medicine in Chicago, IL, while earning a Master of Science degree in clinical investigation. In 2018, she joined the Yale Medicine faculty.

    Dr. Hinchcliff’s passion for treating patients with scleroderma stems from early experiences seeing how severely the disease impacted peoples’ lives. “I’m dedicated to finding a cure,” she says. “In the meantime, I’m working to find better treatments so patients can live as full lives as possible."

    As the director of the Scleroderma Program, Dr. Hinchcliff’s goal is to create a multidisciplinary program that brings doctors from as many specialties as possible together to treat the various aspects of the disease. “Scleroderma is a systemic disease and requires a team care approach in order to achieve the best outcome,” she says. The program also conducts research on treating and understanding the way scleroderma impacts the lungs, heart, gastrointestinal tract, and other organs.

    As a doctor, Dr. Hinchcliff is direct and dedicated. She isn’t afraid to give honest answers about the progression of the disease. “I think my favorite part of being a rheumatologist specializing in scleroderma is when I see a light bulb go off for the patient when they finally understand what they have and they feel some level of relief that help is on the way,” she says.

    In order to understand the patient experience better, she has tried many of the diagnostic procedures (such as skin biopsy) herself. “I wouldn’t ask patients to do anything that I wouldn’t do myself,” she says.

    In addition to seeing patients, Dr. Hinchcliff is the director of clinical research for rheumatology at Yale School of Medicine.

    Clinical Specialties

    Rheumatology

    Fact Sheets

    Yale Medicine News

    Get In Touch

    Contacts

    Administrative Support

    Locations

    • PO BOX 208031

      Academic Office

      The Anlyan Center

      300 Cedar Street, Wing South , Fl 4, Ste 470, Rm C

      New Haven, CT 06519

    • Patient Care Locations

      Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.